SENS Senseonics Holdings, Inc.
$8.33▲ +11.36%
Healthcare
Other
After hours
$8.33▲ +0.00%
Oct 27, 4:01 PM ET
Volume 823.8K
Avg Volume (10D) 535.0K
Key Metrics & Fundamentals
Market Cap
$440.44M
P/E Ratio
–
Div Yield
0.00%
52W Range
4.79 - 10.64
% vs 50 MA
-8.94%
% vs 200 MA
16.22%
RSI-14
46.9
MACD Histogram
-0.1100
Beta (1Y vs SPY)
2.27
Free Cash Flow
-$30.36M
Gross Rev
$14.48M
Gross Profit
$8.56M
EBITDA
-$34.56M
COGS
$5.92M
Operating Exp
$44.55M
Operating Income
-$35.99M
EBIT
-$35.99M
Pretax Income
-$36.71M
Net Income
-$36.71M
EPS (Diluted)
-0.63
Price & Volume History
Loading chart…
Recent News
Senseonics Initiates First-in-Human Clinical Study Evaluating Freedom CGM System
MT Newswires · Oct 26, 2026 9:24 AM ET
Senseonics Initiates First-in-Human Study of Freedom, Designed to be the World’s First CGM System with No On-body Component
GlobeNewswire · Oct 26, 2026 8:00 AM ET
Senseonics Holdings, Inc. to Participate in Upcoming Investor Conferences
GlobeNewswire · Oct 22, 2026 8:00 AM ET
Sensirion (SWX:SENS) Stock May Trade At A Premium To Cash Flow
Simply Wall St. · Oct 22, 2026 6:15 AM ET
Senseonics Holdings, Inc. Schedules Third Quarter 2026 Earnings Release and Conference Call for November 9, 2026 at 4:30 P.M. Eastern Time
GlobeNewswire · Oct 21, 2026 8:00 AM ET
Flutter upgraded, AppFolio downgraded: Wall Street's top analyst calls
The Fly · Oct 7, 2026 10:00 AM ET
Beta Bionics Stock Down Despite iLet-Eversense 365 Integration Deal
Zacks · Sep 29, 2026 10:06 AM ET
Beta Bionics, Senseonics Partner to Integrate Diabetes Devices
MT Newswires · Sep 22, 2026 8:07 AM ET
Senseonics, Beta Bionics Partner on Eversense 365-iLet Diabetes System
MT Newswires · Sep 14, 2026 7:48 AM ET
Senseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense® 365 with the iLet® Bionic Pancreas
GlobeNewswire · Sep 14, 2026 7:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See SENS's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.